To identify the incidence and etiology of shock and implications on mortality and neurologic outcome in patients undergoing therapeutic hypothermia after cardiac arrest. Retrospective chart review of 206 consecutive patients from January 2006 through December 2010. The incidence of shock was 74.8% during cooling and 78.0% during rewarming. The most common etiology of shock during cooling was cardiogenic (46.1%). During rewarming, the etiology of shock was more distributed with 26.9% of patients in cardiogenic shock, 16.8% distributive, and 10.7% classified as mixed. There were no significant associations between shock during cooling or rewarming and survival (P ¼ 0.202, P ¼ 0.107) or neurologic score at discharge (P ¼ 0.377, P ¼ 0.055). Shock is difficult to categorize in the setting of therapeutic hypothermia. The incidence of shock in patients undergoing therapeutic hypothermia is high but not associated with poorer survival or worse neurologic score at discharge. Thus, the presence of shock should not be the limiting factor in decisions regarding aggressive care of the out-of-hospital cardiac arrest patient.
KEY WORDStherapeutic hypothermia, shock, cardiac arrest, survival, neurologic outcome.
n INTRODUCTIONEach year approximately 350,000 people have an out-of-hospital cardiac arrest (OHCA) in the United States.1 In a large meta-analysis, only 23.8% of patients survived to hospital admission and only 7.6% to hospital discharge.2 Prior to therapeutic hypothermia, 25% of the survivors had a poor neurologic outcome.
3The American Heart Association now recommends therapeutic hypothermia for 12 to 24 hours after out-of-hospital ventricular tachycardia/ventricular fibrillation (VT/VF) cardiac arrest as a method to improve neurologic outcomes. 4 This recommendation was based on 2 randomized controlled trials suggesting clear benefit of therapeutic hypothermia.
5,6Therapeutic hypothermia's role in patients presenting in shock is less well defined in the literature. Several small studies have addressed outcomes in patients in shock undergoing therapeutic hypothermia. In 1 study of 50 patients with OHCA secondary to VF undergoing therapeutic hypothermia, patients treated with an intra-aortic balloon pump were compared with those not requiring a balloon pump. Both sets of patients did relatively well with favorable neurologic score, defined as cerebral performance category 1 (good cerebral performance: conscious, alert, able to work, might have mild neurologic or psychologic deficit) or 2 (moderate cerebral disability: conscious, sufficient cerebral function for independent activities of daily life, able to work in sheltered environment), in 61% and 74% (P¼ NS).7 A second study reported the results of 56 patients, 28 with cardiogenic shock, after OHCA with any initial rhythm. In patients with cardiogenic shock, 39% had a favorable neurologic outcome at discharge whereas 71% of the patients not in cardiogenic shock had a favorable neurologic outcome.8 Mooney et al 9 previously described a 38% survival to hospital...